Abstract
With a current worldwide prevalence of 25 % and estimates of 90 % of those living an average lifespan developing hypertension, there is an increasing perception that hypertension is inevitable. Yet the major causes of hypertension (pathogenic diet, lack of physical activity, obesity , and excess alcohol consumption) are known and are potentially amenable to interventions at an individual or more importantly at a societal level. Changing approaches to health-care delivery to ensure the routine provision of effective preventative interventions, ensuring communities are designed to support healthy lifestyles, and that the national and regional governments implement well-known and highly recommended public policies to ensure the places where people live and work are healthy could markedly reduce the prevalence of hypertension. Most of the changes to reduce the prevalence of hypertension require health system and public policy changes. Because increased blood pressure is a major determinant of premature disability and death, clinicians and scientists interested in hypertension should play a much greater role in leading and supporting the changes that are required.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Organization (2009) Global health risks: Mortality and burden of disease attributable to selected major risks. World Health Organization, pp 1–62
Kearney PM, Whelton M, Reynolds K et al (2004) Worldwide prevalence of hypertension: a systematic review. J Hypertens 22:11–19
Egan BM, Zhao Y, Axon RN (2010) US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA 303:2043–2050
Primatesta P (2003) Poulter NR (2006) Improvement in hypertension management in England: results from the Health Survey for England. J Hypertens 24:1193–1200
Meng XJ, Dong GH, Wang D et al (2011) Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: the CHPSNE study. J Hypertens 29:1303–1310
Wagner A, Sadoun A, Dallongeville J et al (2011) High blood pressure prevalence and control in a middle-aged French population and their associated factors: the MONA LISA study. J Hypertens 29:43–50
Wilkins K, Campbell N, Joffres M et al (2010) Blood pressure in Canadian adults. Health Rep 21:1–10
Vasan RS, Beiser A, Seshadri S et al (2002) Residual lifetime risk for developing hypertension in middle-aged women and men. JAMA 287:1003–1010
Lawes CM, Vander Hoorn S, Rodgers A (2008) Global burden of blood-pressure-related disease, 2001. Lancet 371:1513–1518
Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA (2005) Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 85:679–715
Elliott P, Stamler J, Nichols R et al (1996) Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. BMJ 312:1249–1253
He FJ, MacGregor GA (2010) Reducing population salt intake worldwide: from evidence to implementation. Prog Cardiovasc Dis 52:363–382
Steffen PR, Smith TB, Larson M, Butler L (2006) Acculturation to Western society as a risk factor for high blood pressure: a meta-analytic review. Psychosom Med 68:386–397
Jeemon P, Prabhakaran D, Huffman MD et al (2011) Distribution of 10-year and lifetime predicted risk for cardiovascular disease in the Indian Sentinel Surveillance Study population (cross-sectional survey results). BMJ Open 1:e000068
Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104:2746–2753
Gupta R, Gupta R, Agrawal A et al (2011) Migrating husbands and changing cardiovascular risk factors in the wife: a cross sectional study in Asian Indian women. J Epidemiol Community Health 66:881–889
Satia JA, Patterson RE, Kristal AR et al (2001) Development of scales to measure dietary acculturation among Chinese-Americans and Chinese-Canadians. J Am Diet Assoc 101:548–553
Patel JV, Vyas A, Cruickshank JK et al (2006) Impact of migration on coronary heart disease risk factors: comparison of Gujaratis in Britain and their contemporaries in villages of origin in India. Atherosclerosis 185:297–306
Chiu JF, Bell AD, Herman RJ et al (2010) Cardiovascular risk profiles and outcomes of Chinese living inside and outside China. Eur J Cardiovasc Prev Rehabil 17:668–675
Bhatnagar D, Anand IS, Durrington PN et al (1995) Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet 345:405–409
Bainey KR, Jugdutt BI (2009) Increased burden of coronary artery disease in South-Asians living in North America. Need for an aggressive management algorithm. Atherosclerosis 204:1–10
Chiu M, Austin PC, Manuel DG, Tu JV (2011) Cardiovascular risk factor profiles of recent immigrants vs long-term residents of Ontario: a multi-ethnic study. Can J Cardiol 28:20–26
Koya DL, Egede LE (2007) Association between length of residence and cardiovascular disease risk factors among an ethnically diverse group of United States immigrants. J Gen Intern Med 22:841–846
Harding S (2003) Mortality of migrants from the Indian subcontinent to England and Wales: effect of duration of residence. Epidemiology 14:287–292
Madrigal L, Brady J, Raxter M et al (2011) Obesity, hypertension, and migration: a meta-analysis of populations of the South Asian diaspora. Hum Biol 83:71–86
Yusuf S, Hawken S, Ounpuu S et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937–952
Jonnalagadda SS, Diwan S (2005) Health behaviors, chronic disease prevalence and self-rated health of older Asian Indian immigrants in the U.S. J Immigr Health 7:75–83
Popkin BM (2001) Nutrition in transition: the changing global nutrition challenge. Asia Pac J Clin Nutr 10:S13–S18
Danaei G, Finucane MM, Lin JK et al (2011) National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 377:568–577
Kastarinen M, Antikainen R, Peltonen M et al (2009) Prevalence, awareness and treatment of hypertension in Finland during 1982–2007. J Hypertens 27:1552–1559
Hedayati SS, Elsayed EF, Reilly RF (2011) Non-pharmacological aspects of blood pressure management: what are the data? Kidney Int 79:1061–1070
Dickinson HO, Mason JM, Nicolson DJ et al (2006) Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens 24:215–233
National Clinical Guidelines Centre (2004) Hypertension: the clinical management of primary hypertension in adults, vol. 1. National Clinical Guideline Centre, London, pp 1–310
Touyz RM, Campbell N, Logan A et al (2004) The 2004 Canadian recommendations for the management of hypertension: part III—lifestyle modifications to prevent and control hypertension. Can J Cardiol 20:55–59
Rabi DM, Daskalopoulou SS, Padwal RS et al (2011) The 2011 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 27:415–433
Frisoli TM, Schmieder RE, Grodzicki T, Messerli FH (2011) Beyond salt: lifestyle modifications and blood pressure. Eur Heart J 32:3081–3087
Weir MR (2010) Dietary fructose and elevated levels of blood pressure. J Am Soc Nephrol 21:1416–1418
Johnson RJ, Sanchez-Lozada LG, Nakagawa T (2010) The effect of fructose on renal biology and disease. J Am Soc Nephrol 21:2036–2039
Zhao D, Qi Y, Zheng Z et al (2011) Dietary factors associated with hypertension. Nat Rev Cardiol 8:456–465
Hypertension Prevention Trial Research Group (1990) The hypertension prevention trial: three-year effects of dietary changes on blood pressure. Hypertension prevention trial research group. Arch Intern Med 150:153–162
The Trials of Hypertention Prevention Collaborative Research Group (1992) The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. JAMA 267:1213–1220
He J, Whelton PK, Appel LJ et al (2000) Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 35:544–549
Whelton PK, Appel LJ, Espeland MA et al (1998) Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA 279:839–846
Appel LJ, Champagne CM, Harsha DW et al (2003) Effects of comprehensive lifestyle modification on blood pressure control. Main results of the PREMIER clinical trial. JAMA 289:2083–2093
Appel LJ, Moore TJ, Obarzanek E et al (1997) A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336:1117–1124
Sacks FM, Svetkey LP, Vollmer WM et al (2001) Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 344:3–10
Takahashi Y, Sasaki S, Okubo S et al (2006) Blood pressure change in a free-living population-based dietary modification study in Japan. J Hypertens 24:451–458
Gu D, Wildman RP, Wu X et al (2007) Incidence and predictors of hypertension over 8 years among Chinese men and women. J Hypertens 25:517–523
Paynter NP, Cook NR, Everett BM et al (2009) Prediction of incident hypertension risk in women with currently normal blood pressure. Am J Med 122:464–471
Grebla RC, Rodriguez CJ, Borrell LN, Pickering TG (2009) Prevalence and determinants of isolated systolic hypertension among young adults: the 1999–2004 US national health and nutrition examination survey. J Hypertens 27:15–23
World Health Organization (2008) WHO global strategy on diet, physical activity and health: a framework to monitor and evaluate implementation. World Health Organization, Geneva, Switzerland
World Health Organization (2010) WHO—A prioritized research agenda for prevention and control of noncommunicable diseases. WHO, Geneva, Switzerland, pp 1–23
Barr VJ, Robinson S, Marin-Link B et al (2003) The expanded chronic care model: an integration of concepts and strategies from population health promotion and the chronic care model. Hosp Q 7:73–82
Campbell N, Young ER, Drouin D et al (2012) A framework for discussion on how to improve prevention, management and control of hypertension in Canada. Can J Cardiol 28:262–269
Healthy People. Healthy People 2020 Objectives. http://healthypeople.gov
Danaei G, Ding EL, Mozaffarian D et al (2009) The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle < and metabolic risk factors. PLoS Med 6:e1000058
Olshansky SJ, Passaro DJ, Hershow RC et al (2005) A potential decline in life expectancy in the United States in the 21st century. N Eng J Med 352:1138–1145
Beaglehole R, Bonita R, Horton R et al (2011) Priority actions for the non-communicable disease crisis. Lancet 377:1438–1447
World Health Organization (2009) Global health risks: mortality and burden of disease attributable to selected major risks. World Health Organization, Switzerland, Geneva
Papadakis S, Moroz I (2008) Population-level interventions for coronary heart disease prevention: what have we learned since the North Karelia project? Curr Opin Cardiol 23:452–461
World Health Organization (2003) Diet, Nutrition and the prevention of chronic diseases: report of a joint WHO/FAO Epert consultation, vol 1. World Health Organization, Geneva, Switzerland, pp 1–149
World Health Organization (2003) WHO framework convention on tobacco control. World Health Organization, Geneva, Switzerland
World Health Organization (2007) Prevention of cardiovascular disease. Guidelines for assessment and management of cardiovascular risk. World Health Organization, World Health Press Geneva, Switzerland, pp 1–92
World Health Organization (2007) Reducing salt intake in populations: report of a WHO forum and technical meeting 5–7 october 2006. WHO 1:1–56
World Health Organization (2009) Interventions on diet and physical activity: what works: summary report. WHO 1–48
World Health Organization (2008) 2008–2013 action plan for global strategy for the prevention and control of noncommunicable diseases: prevent and control cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. WHO 1–42
World Health Organization (2011) Creating an enabling environment for population-based salt reduction strategies. Report of a joint technical meeting held by WHO and the Food Standards Agency, vol 1, No 1. WHO Press, Geneva, July 2010, pp 3–42
Barr VJ, Robinson S, Marin-Link B et al (2003) The expanded chronic care model: an integration of concepts and strategies from population health promotion and the chronic care model. Hosp Q 7:73–82
Karwalajtys T, Kaczorowski J (2010) An integrated approach to preventing cardiovascular disease: community-based approaches, health system initiatives, and public health policy. Risk Manag Healthc Policy 3:39–48
Institute of Medicine of the National Academies (2004) Health literacy. A prescription to end confusion. Institute of Medicine of the National Academies, Washington
Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs AMA (1999) Health literacy: report of the council on scientific affairs. JAMA 281:552–557
Jones CA, Mawani S, King KM et al (2011) Tackling health literacy: adaptation of public hypertension educational materials for an Indo-Asian population in Canada. BMC Public Health 11:1–11
Gee ME, Bienek A, Campbell NR et al (2011) Prevalence of and barriers to, preventive lifestyle behaviors in hypertension (from a national survey of Canadians with hypertension). Am J Cardiol 109:570–574
Lopez L, Cook EF, Horng MS, Hicks LS (2009) Lifestyle modification counseling for hypertensive patients: results from the National Health and Nutrition Examination Survey 1999–2004. Am J Hyperten 22:325–331
Glynn LG, Murphy AW, Smith SM et al (2010) Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev 3:CD005182
Kotchen TA (2010) The search for strategies to control hypertension. Circulation 122:1141–1143
Lewanczuk R (2006) Innovations in primary care: Implications for hypertensiondetection and treatment. Can J Cardiol 22:614–616
Lewanczuk R (2008) Hypertension as a chronic disease: what can be done at a regional level? Can J Cardiol 24:483–484
Coleman K, Mattke S, Perrault PJ, Wagner EH (2009) Untangling practice redesign from disease management: how do we best care for the chronically ill? Annu Rev Public Health 30:385–408
Ho PM, Rumsfeld JS (2006) Beyond inpatient and outpatient care: alternative model for hypertension management. BMC Public Health 6:257
Milder IE, Blokstra A, de Groot J et al (2008) Lifestyle counseling in hypertension-related visits–analysis of video-taped general practice visits. BMC Fam Pract 9:58
Fleming MF, Barry KL, Manwell LB et al (1997) Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices. JAMA 277:1039–1045
Cromwell J, Bartosch WJ, Fiore MC et al (1997) Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. JAMA 278:1759–1766
Elmer PJ, Obarzanek E, Vollmer WM et al (2006) Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 144:485–495
Committee on Public Health Priorities to Reduce and Control Hypertension in the U.S. Population Institute of Medicine (2011) A population-based policy and systems change approach to prevent and control hypertension. Institute of Medicine, Washington, pp 1–187
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Jones, C., Campbell, N.R.C. (2012). Can Hypertension Be Prevented?. In: Berbari, A., Mancia, G. (eds) Special Issues in Hypertension. Springer, Milano. https://doi.org/10.1007/978-88-470-2601-8_31
Download citation
DOI: https://doi.org/10.1007/978-88-470-2601-8_31
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2600-1
Online ISBN: 978-88-470-2601-8
eBook Packages: MedicineMedicine (R0)